ReviewCardio-oncology (London, England)2024

Cardiac adverse events after Chimeric Antigen Receptor (CAR) T cell therapies: an updated systematic review and meta-analysis.

Saba Maleki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.